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Polyglutamylation makes the cut
L
acroix et al. report that 
the addition of long 
glutamate side chains 
to tubulin stimulates microtu-
bule disassembly by the micro-
tubule-severing protein spastin.
The C-terminal tails of 
tubulin subunits can be modi-
fi  ed in different ways, which 
might alter the recruitment of 
molecular motors and other microtubule-binding proteins. A family 
of glutamylase enzymes generates glutamate side chains of varying 
lengths on tubulin tails. The purpose of this modifi  cation isn’t clear, 
though it may stimulate microtubule severing: in the protozoan 
Tetrahymena, blocking tubulin glutamylation has a similar effect 
to deleting the microtubule-severing protein katanin.
Lacroix et al. transfected HeLa cells with different glutamy-
lases and found that enzymes that added long glutamate side chains 
to tubulin stimulated microtubule disassembly. The addition of 
shorter chains by other family members had no effect. The micro-
tubules were disassembled by the severing protein spastin, whose 
activity was boosted by the polyglutamylated tubulin tails—possibly 
because the negatively charged glutamate residues attract a positively 
charged region of spastin’s active site. Microtubules assembled in 
vitro from polyglutamylated tubulin were quickly dismantled by 
spastin, while non-glutamylated microtubules were more stable.
Spastin’s activity is reduced by mutations associated with 
spastic paraplegia; defects in tubulin polyglutamylation might 
therefore cause neurodegeneration as well. Senior author Carsten 
Janke thinks that the modifi  cation facilitates microtubule cutting 
by spastin and katanin, but that additional signals ensure fi  laments 
are only disassembled at the right moment. He now plans to 
investigate how polyglutamylation affects the activity of other 
microtubule-interacting proteins, such as molecular motors.
Lacroix, B., et al. 2010. J. Cell Biol. doi:10.1083/jcb.201001024.
Deconstructing FAK function
F
ocal adhesion kinase 
(FAK) has multiple 
functions in endothelial 
cells, but only some of them 
require the protein’s kinase 
activity, Zhao et al. report.
FAK promotes the mi-
gration and survival of many 
cell types, including endothe-
lial cells. Mice lacking FAK 
in their vascular system die before birth due to defects in angio-
genesis, but how FAK supports blood vessel development is 
unclear. In vitro experiments suggest that FAK sometimes 
acts as an adaptor for other kinases instead of phosphorylating 
target proteins itself. To investigate whether FAK’s kinase 
activity is required for angiogenesis, Zhao et al. generated mice 
that only express a kinase-deficient version of the protein in 
their vasculature.
Although these mice still died before birth, they survived for a 
couple of days longer than animals without any FAK in their vascular 
system. Endothelial cells completely lacking FAK are prone to apop-
tosis, but kinase-dead FAK boosted cell survival by suppressing the 
cyclin-dependent kinase inhibitor p21. But other problems emerged 
as the embryos developed further: blood vessels were dilated and 
fewer in number. The researchers found that endothelial cell layers 
are more permeable in the absence of FAK due to mislocalization 
and reduced phosphorylation of the adhesion protein VE-cadherin. 
These defects weren’t rescued by the kinase-defi  cient mutant.
FAK therefore has kinase-dependent and -independent func-
tions in endothelial cells. The same may be true in cancer cells, says 
senior author Jun-Lin Guan, so drugs that only target FAK’s kinase 
activity may not prevent the protein from promoting metastasis.
Zhao, X., et al. 2010. J. Cell Biol. doi:10.1083/jcb.200912094.
Apoptotic cells (red) are found in 
blood vessels (green) lacking FAK 
(left), but are absent from vessels 
expressing a kinase-deﬁ  cient mu-
tant (right).
Acid sphingomyelinase deals the seal
C
ells repair holes in 
their plasma mem-
brane by secreting a 
lysosomal hydrolase to induce 
endocytosis, Tam et al. reveal.
If their outer surface is 
punctured by scraping or by 
pore-forming bacterial toxins, 
cells quickly fuse their lyso-
somes with the plasma membrane, which might provide extra 
lipids to patch the leak. But puncture repair also involves the 
removal of damaged plasma membrane by endocytosis. Tam et 
al. wondered whether the two processes were linked and found 
that blocking lysosome exocytosis in injured cells prevented 
endocytosis and plasma membrane repair.
How does lysosome secretion stimulate the internalization of 
damaged membrane? The endosomes generated during membrane 
repair look like the vesicles produced by cells exposed to the bacterial 
enzyme sphingomyelinase, which induces membrane budding 
by forming ceramide patches on the cell surface. The authors 
thought that secretion of the lysosomal version of this enzyme, acid 
sphingomyelinase (ASM), could have a similar effect and found that 
an ASM inhibitor blocked endocytosis and puncture repair. Cells 
lacking ASM—including fi   broblasts derived from patients with 
Niemann-Pick disease type A—were also defi  cient in resealing their 
membranes after damage, but endocytosis and membrane repair 
were restored by adding ASM protein to the cells’ medium.
Defective membrane repair may therefore contribute to the 
neurodegenerative pathology of Niemann-Pick type A, which was 
previously ascribed largely to the intracellular accumulation of 
sphingomyelin and cholesterol. First author Christina Tam and senior 
author Norma Andrews now want to determine whether other lyso-
somal hydrolases stimulate endocytosis and membrane resealing.
Tam, C., et al. 2010. J. Cell Biol. doi:10.1083/jcb.201003053.
Cells expressing the polyglutamylase 
TTLL6 (cyan) lose their microtubules 
(red) because the ﬁ  lament-severing 
protein spastin is hyperactivated.
When ASM is inhibited (right), the 
holes produced by a bacterial toxin 
aren’t resealed, allowing a lipophilic 
dye (green) to enter the cells.